.Merck beats incomes desires, raises purchases overview on sturdy requirement for best medications like Keytruda CNBCMerck & Co. (MRK US) Defeats Income Estimates as Keytruda Purchases Surge BloombergMerck Supply: Pharma Titan Posts Solid Outcomes, However Expectation Falls Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps earnings and also purchases desires among Keytruda asset, however delivers mixed full-year outlook MarketWatch.